Kuros Biosciences AG (SWX:KURN)
Switzerland
· Delayed Price · Currency is CHF 21.50
-0.42 (-1.92%)
Apr 29, 2026, 12:50 PM CET
Kuros Biosciences AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2.55 | -4.84 | -16.3 | -15.78 | -8.27 | Upgrade
|
| Depreciation & Amortization | 3.36 | 2.94 | 3.21 | 2.97 | 3.08 | Upgrade
|
| Other Amortization | 0.01 | 0.03 | 0.06 | 0.09 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 5.75 | 5.39 | 3.89 | - | Upgrade
|
| Stock-Based Compensation | 4.2 | 5.78 | 1.09 | 1.11 | 0.43 | Upgrade
|
| Other Operating Activities | 5.07 | -1.28 | 4.63 | 1.13 | -1.09 | Upgrade
|
| Change in Accounts Receivable | -22.61 | -8.89 | -5.43 | -1.77 | -0.81 | Upgrade
|
| Change in Inventory | -9.94 | -5.72 | -2.94 | -1.71 | -0.37 | Upgrade
|
| Change in Accounts Payable | 5.43 | 6.28 | 0.07 | 0.53 | - | Upgrade
|
| Change in Other Net Operating Assets | 11.38 | 4.13 | 3.97 | 1.59 | 0.97 | Upgrade
|
| Operating Cash Flow | -0.46 | 3.54 | -10.5 | -7.95 | -5.99 | Upgrade
|
| Capital Expenditures | -2.44 | -1.23 | -0.38 | -0.43 | -0.33 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.02 | -0.01 | -0.01 | -0.08 | Upgrade
|
| Investing Cash Flow | -2.44 | -1.25 | -0.39 | -0.43 | -0.41 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 7.02 | Upgrade
|
| Total Debt Issued | - | - | - | - | 7.02 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -2.57 | - | Upgrade
|
| Long-Term Debt Repaid | -0.78 | -0.68 | -0.8 | -0.37 | -0.35 | Upgrade
|
| Total Debt Repaid | -0.78 | -0.68 | -0.8 | -2.94 | -0.35 | Upgrade
|
| Net Debt Issued (Repaid) | -0.78 | -0.68 | -0.8 | -2.94 | 6.67 | Upgrade
|
| Issuance of Common Stock | 2.19 | 2.19 | 0.59 | 6.49 | - | Upgrade
|
| Other Financing Activities | - | - | - | -0.06 | - | Upgrade
|
| Financing Cash Flow | 1.41 | 1.51 | -0.2 | 3.49 | 6.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.49 | -0.72 | -0.61 | -0.04 | -0.01 | Upgrade
|
| Net Cash Flow | 0.01 | 3.07 | -11.71 | -4.93 | 0.26 | Upgrade
|
| Free Cash Flow | -2.89 | 2.31 | -10.88 | -8.37 | -6.32 | Upgrade
|
| Free Cash Flow Margin | -1.98% | 2.71% | -27.29% | -43.05% | -41.72% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | 0.06 | -0.30 | -0.25 | -0.19 | Upgrade
|
| Cash Interest Paid | 0.16 | 0.03 | 0.07 | 0.09 | 0.13 | Upgrade
|
| Cash Income Tax Paid | 1.6 | 0.98 | 0.65 | 0 | 0.05 | Upgrade
|
| Levered Free Cash Flow | -3.93 | 4.63 | -10.15 | -4.84 | 5.75 | Upgrade
|
| Unlevered Free Cash Flow | -3.7 | 4.74 | -10.01 | -4.84 | 6.69 | Upgrade
|
| Change in Working Capital | -15.74 | -4.2 | -4.33 | -1.37 | -0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.